TrialScientific reports2019

Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer.

Yi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.